- Home
- PLSE vs SBGI Comparison
PLSE vs SBGI Comparison
Compare PLSE & SBGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PLSE | SBGI |
|---|---|---|
| Founded | 2014 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Broadcasting |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.0B |
| IPO Year | 2015 | 2023 |
Fundamental Metrics
Financial Performance| Metric | PLSE | SBGI |
|---|---|---|
| Price | $25.37 | $14.49 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 5 |
| Target Price | ★ $22.00 | $21.00 |
| AVG Volume (30 Days) | ★ 404.9K | 321.0K |
| Earning Date | 05-30-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 6.65% |
| EPS Growth | N/A | ★ 205.16 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $3,548,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1,250.20 | $8.28 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 13.21 |
| 52 Week Low | $12.56 | $11.89 |
| 52 Week High | $26.30 | $17.88 |
Technical Indicators
Market Signals| Indicator | PLSE | SBGI |
|---|---|---|
| Relative Strength Index (RSI) | 71.93 | 46.16 |
| Support Level | $22.93 | $14.37 |
| Resistance Level | $25.80 | $15.32 |
| Average True Range (ATR) | 2.17 | 0.57 |
| MACD | 0.78 | 0.08 |
| Stochastic Oscillator | 91.60 | 55.78 |
Price Performance
Historical ComparisonAbout PLSE Pulse Biosciences Inc (DE)
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.
About SBGI Sinclair Inc.
Sinclair Inc. is the owner-operator of the second largest portfolio of television stations in the United States, with 185 full power stations in 86 markets, covering 40% of US households. Of the firm's roughly 600 channels, 150 are affiliated with the four national broadcasters—Fox, ABC, CBS, and NBC—with over 80 other channels aligned with The CW (Nexstar) and MyNetworkTV (Fox). Sinclair owns the Tennis Channel and stakes in Marquee Sports Network and YES Network, providing their premium sports content to pay-TV distributors.